医学期刊排名
Endocrine Metabolic & Immune Disorders-Drug Targets

期刊介绍

This journal is devoted to full-length/ mini-reviews and original articles based on experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions. Moreover, the topics related to the effects of food components and/or nutraceuticals on the endocrine-metabolic-immune axis and on microbiome composition are welcome. The journal’s scope also covers neuroendocrinology, reproductive endocrinology, hormone secretion, and their effects on different organs.

该期刊致力于基于内分泌、代谢和免疫疾病领域的实验和临床研究的全长/迷你评论和原创文章。特别强调天然、合成和基因工程药物的体液和细胞靶标,这些药物可增强或损害内分泌、代谢和免疫参数和功能。此外,与食品成分和/或营养保健品对内分泌 - 代谢 - 免疫轴和微生物组组成的影响相关的主题是受欢迎的。该杂志的范围还包括神经内分泌学,生殖内分泌学,激素分泌及其对不同器官的影响。发稿量适中,相对友好,推荐投稿
 
 
 
全名/缩写 ENDOCR METAB IMMUNE/Endocrine Metabolic & Immune Disorders-Drug Targets
期刊ISSN 1871-5303
2022-2023影响因子 2.387 实时影响因子查询 (由greensci.net提供-2019 New!)
最新自引率 2.50
期刊官方网站 http://benthamscience.com/journal/index.php?journalID=emiddt
是否OA开放访问 No
出版国家或地区 U ARAB EMIRATES
出版年份 0
中科院JCR分区 大类:4区小类:4区
SCI期刊coverage Science Citation Index Expanded
审稿速度(网友添加,非官方)  

×

绿色通道审稿 加急发表
可添加微信号:meibisi123

稍后再说 立刻咨询